Once known mainly for their role in weight management, GLP-1 receptor agonists, like semaglutide and tirzepatide, are now ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

The GLP-1 medication program by MedVi is now available nationwide starting at $179. NEWARK, DE - MedVi Wellness, a leading tele ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

Another study linked GLP-1 receptor agonist use with higher odds of developing nonarteritic anterior ischemic optic ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

GLP-1 receptor agonist medications have revolutionized weight management and diabetes treatment, offering significant benefits for millions of patients worldwide. However, these powerful ...

For patients with idiopathic intracranial hypertension, GLP-1 RA treatment is linked with improved clinical outcomes compared with conventional therapies.

Glucagon-like peptide-1 (GLP-1) receptor agonists used in patients with diabetes are associated with reduced risks of dozens of outcomes—as well as increased risks of others—when compared with other ...

The Extended Lifespan of GLP-1 Receptor Agonist Drugs from the Discovery of Pleiotropic Effects Glucagon-like peptide-1 (GLP-1) was first discovered in the 1980s as a regulator of glucose levels.